Agapios Sachinidis
Agapios Sachinidis
Professor of Physiology
Verified email at - Homepage
Cited by
Cited by
Cardiac specific differentiation of mouse embryonic stem cells
A Sachinidis, BK Fleischmann, E Kolossov, M Wartenberg, H Sauer, ...
Cardiovascular research 58 (2), 278-291, 2003
Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells
G Nickenig, A Sachinidis, F Michaelsen, M Bo¨ hm, S Seewald, H Vetter
Circulation 95 (2), 473-478, 1997
A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity
L Ding, M Paszkowski-Rogacz, A Nitzsche, MM Slabicki, AK Heninger, ...
Cell stem cell 4 (5), 403-415, 2009
A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction
S Fronhoffs, G Totzke, S Stier, N Wernert, M Rothe, T Brüning, B Koch, ...
Molecular and cellular probes 16 (2), 99-110, 2002
Epigallocathechin-3 gallate selectively inhibits the PDGF-BB–induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of …
HY Ahn, KR Hadizadeh, C Seul, YP Yun, H Vetter, A Sachinidis
Molecular biology of the cell 10 (4), 1093-1104, 1999
Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach
AK Krug, R Kolde, JA Gaspar, E Rempel, NV Balmer, K Meganathan, ...
Archives of toxicology 87 (1), 123-143, 2013
Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases
S Jagtap, K Meganathan, V Wagh, J Winkler, J Hescheler, A Sachinidis
Current medicinal chemistry 16 (12), 1451-1462, 2009
Current challenges of iPSC-based disease modeling and therapeutic implications
MX Doss, A Sachinidis
Cells 8 (5), 403, 2019
Embryonic stem cells: a promising tool for cell replacement therapy
MX Doss, CI Koehler, C Gissel, J Hescheler, A Sachinidis
Journal of cellular and molecular medicine 8 (4), 465-473, 2004
Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells.
LH Block, LR Emmons, E Vogt, A Sachinidis, W Vetter, J Hoppe
Proceedings of the National Academy of Sciences 86 (7), 2388-2392, 1989
Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells.
A Sachinidis, R Locher, W Vetter, D Tatje, J Hoppe
Journal of Biological Chemistry 265 (18), 10238-10243, 1990
Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells
P Godoy, W Schmidt-Heck, K Natarajan, B Lucendo-Villarin, D Szkolnicka, ...
Journal of Hepatology 63 (4), 934-942, 2015
Thromboxane A2 and Vascular Smooth Muscle Cell Proliferation
A Sachinidis, M Flesch, Y Ko, K Schrör, M Böhm, R Düsing, H Vetter
Hypertension 26 (5), 771-780, 1995
Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue
Y Ko, J Abel, V Harth, P Bröde, C Antony, S Donat, HP Fischer, ...
Cancer research 61 (11), 4398-4404, 2001
Maximum Diastolic Potential of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Depends Critically on IKr
MX Doss, JM Di Diego, RJ Goodrow, Y Wu, JM Cordeiro, VV Nesterenko, ...
PloS one 7 (7), e40288, 2012
Toxicogenomics directory of chemically exposed human hepatocytes
M Grinberg, RM Stöber, K Edlund, E Rempel, P Godoy, R Reif, A Widera, ...
Archives of toxicology 88 (12), 2261-2287, 2014
Green tea compounds inhibit tyrosine phosphorylation of PDGF β‐receptor and transformation of A172 human glioblastoma
A Sachinidis, C Seul, S Seewald, HY Ahn, Y Ko, H Vetter
FEBS letters 471 (1), 51-55, 2000
Stromal cell‐derived factor 1α (SDF‐1α) induces gene‐expression of early growth response‐1 (Egr‐1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell …
T Neuhaus, S Stier, G Totzke, E Gruenewald, S Fronhoffs, A Sachinidis, ...
Cell proliferation 36 (2), 75-86, 2003
Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood.
Y Ko, M Klinz, G Totzke, I Gouni-Berthold, A Sachinidis, H Vetter
Clinical cancer research: an official journal of the American Association …, 1998
Induced pluripotent stem cells as a model for accelerated patient-and disease-specific drug discovery
I Gunaseeli, MX Doss, C Antzelevitch, J Hescheler, A Sachinidis
Current medicinal chemistry 17 (8), 759-766, 2010
The system can't perform the operation now. Try again later.
Articles 1–20